176 related articles for article (PubMed ID: 23666493)
1. Acute and subacute effects of the selective serotonin-noradrenaline reuptake inhibitor duloxetine on cardiac hERG channels.
Fischer F; Vonderlin N; Seyler C; Zitron E; Schernus B; Katus H; Scholz E
Naunyn Schmiedebergs Arch Pharmacol; 2013 Sep; 386(9):795-804. PubMed ID: 23666493
[TBL] [Abstract][Full Text] [Related]
2. Selective noradrenaline reuptake inhibitor atomoxetine directly blocks hERG currents.
Scherer D; Hassel D; Bloehs R; Zitron E; von Löwenstern K; Seyler C; Thomas D; Konrad F; Bürgers HF; Seemann G; Rottbauer W; Katus HA; Karle CA; Scholz EP
Br J Pharmacol; 2009 Jan; 156(2):226-36. PubMed ID: 19154426
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of cardiac HERG currents by the DNA topoisomerase II inhibitor amsacrine: mode of action.
Thomas D; Hammerling BC; Wu K; Wimmer AB; Ficker EK; Kirsch GE; Kochan MC; Wible BA; Scholz EP; Zitron E; Kathöfer S; Kreye VA; Katus HA; Schoels W; Karle CA; Kiehn J
Br J Pharmacol; 2004 Jun; 142(3):485-94. PubMed ID: 15148258
[TBL] [Abstract][Full Text] [Related]
4. Anesthetic drug midazolam inhibits cardiac human ether-à-go-go-related gene channels: mode of action.
Vonderlin N; Fischer F; Zitron E; Seyler C; Scherer D; Thomas D; Katus HA; Scholz EP
Drug Des Devel Ther; 2015; 9():867-77. PubMed ID: 25733807
[TBL] [Abstract][Full Text] [Related]
5. Clomipramine block of the hERG K+ channel: accessibility to F656 and Y652.
Jo SH; Hong HK; Chong SH; Won KH; Jung SJ; Choe H
Eur J Pharmacol; 2008 Sep; 592(1-3):19-25. PubMed ID: 18634780
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of zolpidem-induced long QT syndrome: acute inhibition of recombinant hERG K(+) channels and action potential prolongation in human cardiomyocytes derived from induced pluripotent stem cells.
Jehle J; Ficker E; Wan X; Deschenes I; Kisselbach J; Wiedmann F; Staudacher I; Schmidt C; Schweizer PA; Becker R; Katus HA; Thomas D
Br J Pharmacol; 2013 Mar; 168(5):1215-29. PubMed ID: 23061993
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cardiac hERG potassium channels by tetracyclic antidepressant mianserin.
Scherer D; von Löwenstern K; Zitron E; Scholz EP; Bloehs R; Kathöfer S; Thomas D; Bauer A; Katus HA; Karle CA; Kiesecker C
Naunyn Schmiedebergs Arch Pharmacol; 2008 Jul; 378(1):73-83. PubMed ID: 18458880
[TBL] [Abstract][Full Text] [Related]
8. Blocking of the human ether-à-go-go-related gene channel by imatinib mesylate.
Dong Q; Fu XX; Du LL; Zhao N; Xia CK; Yu KW; Cheng LX; Du YM
Biol Pharm Bull; 2013; 36(2):268-75. PubMed ID: 23196655
[TBL] [Abstract][Full Text] [Related]
9. Block of hERG K+ channel and prolongation of action potential duration by fluphenazine at submicromolar concentration.
Hong HK; Lee BH; Park MH; Lee SH; Chu D; Kim WJ; Choe H; Hee Choi B; Jo SH
Eur J Pharmacol; 2013 Feb; 702(1-3):165-73. PubMed ID: 23395964
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cardiac HERG potassium channels by the atypical antidepressant trazodone.
Zitron E; Kiesecker C; Scholz E; Lück S; Bloehs R; Kathöfer S; Thomas D; Kiehn J; Kreye VA; Katus HA; Schoels W; Karle CA
Naunyn Schmiedebergs Arch Pharmacol; 2004 Aug; 370(2):146-56. PubMed ID: 15322737
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of human ether-a-go-go-related gene potassium channels by alpha 1-adrenoceptor antagonists prazosin, doxazosin, and terazosin.
Thomas D; Wimmer AB; Wu K; Hammerling BC; Ficker EK; Kuryshev YA; Kiehn J; Katus HA; Schoels W; Karle CA
Naunyn Schmiedebergs Arch Pharmacol; 2004 May; 369(5):462-72. PubMed ID: 15098086
[TBL] [Abstract][Full Text] [Related]
12. Blockade of HERG human K+ channels by the antidepressant drug paroxetine.
Lee SH; Sung MJ; Lee HM; Chu D; Hahn SJ; Jo SH; Choe H; Choi BH
Biol Pharm Bull; 2014; 37(9):1495-504. PubMed ID: 25177033
[TBL] [Abstract][Full Text] [Related]
13. The human ether-a'-go-go related gene (hERG) K+ channel blockade by the investigative selective-serotonin reuptake inhibitor CONA-437: limited dependence on S6 aromatic residues.
Alexandrou AJ; Milnes JT; Sun SZ; Fermini B; Kim SC; Jenkinson S; Leishman DJ; Witchel HJ; Hancox JC; Leaney JL
J Physiol Pharmacol; 2014 Aug; 65(4):511-23. PubMed ID: 25179083
[TBL] [Abstract][Full Text] [Related]
14. Effect of azelastine on cardiac repolarization of guinea-pig cardiomyocytes, hERG K⁺ channel, and human L-type and T-type Ca²⁺ channel.
Park MH; Lee SH; Chu DH; Won KH; Choi BH; Choe H; Jo SH
J Pharmacol Sci; 2013 Sep; 123(1):67-77. PubMed ID: 24005046
[TBL] [Abstract][Full Text] [Related]
15. Atypical tetracyclic antidepressant maprotiline is an antagonist at cardiac hERG potassium channels.
Kiesecker C; Alter M; Kathöfer S; Zitron E; Scholz EP; Thomas D; Kreuzer J; Katus HA; Bauer A; Karle CA
Naunyn Schmiedebergs Arch Pharmacol; 2006 Jun; 373(3):212-20. PubMed ID: 16736158
[TBL] [Abstract][Full Text] [Related]
16. Class Ia anti-arrhythmic drug ajmaline blocks HERG potassium channels: mode of action.
Kiesecker C; Zitron E; Lück S; Bloehs R; Scholz EP; Kathöfer S; Thomas D; Kreye VA; Katus HA; Schoels W; Karle CA; Kiehn J
Naunyn Schmiedebergs Arch Pharmacol; 2004 Dec; 370(6):423-35. PubMed ID: 15599706
[TBL] [Abstract][Full Text] [Related]
17. Effects of donepezil on hERG potassium channels.
Chae YJ; Lee HJ; Jeon JH; Kim IB; Choi JS; Sung KW; Hahn SJ
Brain Res; 2015 Feb; 1597():77-85. PubMed ID: 25498859
[TBL] [Abstract][Full Text] [Related]
18. Direct block of hERG potassium channels by the protein kinase C inhibitor bisindolylmaleimide I (GF109203X).
Thomas D; Hammerling BC; Wimmer AB; Wu K; Ficker E; Kuryshev YA; Scherer D; Kiehn J; Katus HA; Schoels W; Karle CA
Cardiovasc Res; 2004 Dec; 64(3):467-76. PubMed ID: 15537500
[TBL] [Abstract][Full Text] [Related]
19. Protriptyline block of the human ether-à-go-go-related gene (HERG) K+ channel.
Jo SH; Hong HK; Chong SH; Choe H
Life Sci; 2008 Jan; 82(5-6):331-40. PubMed ID: 18191158
[TBL] [Abstract][Full Text] [Related]
20. Anticholinergic antiparkinson drug orphenadrine inhibits HERG channels: block attenuation by mutations of the pore residues Y652 or F656.
Scholz EP; Konrad FM; Weiss DL; Zitron E; Kiesecker C; Bloehs R; Kulzer M; Thomas D; Kathöfer S; Bauer A; Maurer MH; Seemann G; Katus HA; Karle CA
Naunyn Schmiedebergs Arch Pharmacol; 2007 Dec; 376(4):275-84. PubMed ID: 17965852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]